Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,394
datasets available to search
ShareScore release 0.9.0
Dataset results
2,394 results for “ms”
Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT01080053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of ACTHAR on Advanced MRI Surrogate Markers of Disease Activity and on Comprehensive Immune Signature During MS Relapses
ClinicalTrials.gov study NCT03021317. IPD Sharing: NO. Countries: 0. Publications: 0.
Scan-Rescan Sub-Study of MS PATHS
ClinicalTrials.gov study NCT04123353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS Patients
ClinicalTrials.gov study NCT07085507. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of I-TRAVLE Training on Arm Function in MS and Chronic Stroke Patients
ClinicalTrials.gov study NCT01918748. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Assessment of Ocrelizumab (OCR) Treatment Effects on Functional Impairment of MS Patients Enrolled in the Phase III Orchestra Programme Using Multimodal Evoked Potentials (EP) and Highresolution Elect
ClinicalTrials.gov study NCT01765361. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Diagnosis of ON With or Without MS or NMOSD
ClinicalTrials.gov study NCT04131764. IPD Sharing: NO. Countries: 1. Publications: 0.
Computerized Cognition Testing and Cognitive Motor Interference in MS
ClinicalTrials.gov study NCT02318576. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms
ClinicalTrials.gov study NCT03005119. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized, Placebo Controlled Study to Evaluate the Safety and Potential Efficacy of MS-20 in Combination with Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
ClinicalTrials.gov study NCT04909034. IPD Sharing: NO. Countries: 1. Publications: 0.
Prediction of Non-motor Symptoms in Fully Ambulatory MS Patients Using Vocal Biomarkers
ClinicalTrials.gov study NCT05561621. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Computerized Cognitive Training in Persons With MS
ClinicalTrials.gov study NCT05345288. IPD Sharing: NO. Countries: 1. Publications: 0.
Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT05705986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phenotypic and Functional Study of 4BL B Cells in Multiple Sclerosis (MS)
ClinicalTrials.gov study NCT03796611. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effects of MS Ballroom Fitness on Balance, Walking Capacity, and Well-being in Multiple Sclerosis
ClinicalTrials.gov study NCT06028776. IPD Sharing: NO. Countries: 1. Publications: 0.
An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS
ClinicalTrials.gov study NCT00206648. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)
ClinicalTrials.gov study NCT01706055. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity
ClinicalTrials.gov study NCT01538225. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Use of Technology to Improve MS Clinical Trials and Patient Care
ClinicalTrials.gov study NCT02454907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay.
ClinicalTrials.gov study NCT00618267. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.